|1.||Jennings, Heath R: 1 article (12/2006)|
|2.||Voils, Stacy A: 1 article (12/2006)|
|3.||Pesaturo, Adam B: 1 article (12/2006)|
|4.||Wilson, Thomas A: 1 article (07/2006)|
|5.||Aijaz, Naghma: 1 article (07/2006)|
|6.||Blanco, Ernesto J: 1 article (07/2006)|
|7.||Blumberg, Denise: 1 article (07/2006)|
|8.||Lane, Andrew H: 1 article (07/2006)|
|9.||Ouattara, Alexandre: 1 article (06/2003)|
|10.||Coriat, Pierre: 1 article (06/2003)|
|1.||Amnesia (Dissociative Amnesia)
07/01/1977 - "A single injection of lysine vasopressin (1 microgram/rat SC) administered 1 hr prior to either the acquisition trial or 24 hr retention trial antagonized the amnesia."
05/01/1985 - "Arginine- and lysine-vasopressin also reversed the amnesia at a dose of 100 micrograms/body. "
03/01/1982 - "Amnesia in mice for a passive avoidance response induced by anisomycin injection immediately after training was reversed by 40 micrograms of lysine-vasopressin given one hour before testing. "
03/01/1982 - "Alleviation of anisomycin-induced amnesia by pre-test treatment with lysine- vasopressin."
03/01/1980 - "The effect of lysine vasopressin on diethyldithiocarbamate-induced amnesia for a step-through passive avoidance task was studied in rats. "
|2.||Hypotension (Low Blood Pressure)
09/01/1987 - "Effects of inhibition of alpha 1-(prazosin) and alpha 2-(yohimbine) adrenoreceptors on plasma lysine vasopressin concentration during normotension and hemorrhagic hypotension were studied in unanesthetized newborn pigs. "
01/01/1990 - "We assessed the efficacy of intranasal lysine vasopressin (LV) in 6 patients with refractory hemodialysis-induced hypotension. "
01/01/1990 - "Lysine vasopressin in the treatment of refractory hemodialysis-induced hypotension."
06/01/2003 - "Terlipressin, a precursor that is metabolized to lysine-vasopressin, has been proposed as a drug for treatment of intraoperative arterial hypotension refractory to ephedrine in patients who have received long-term treatment with renin-angiotensin system inhibitors. "
02/01/1966 - "Diabetes insipidus: a two year study with 8-lysine vasopressin."
01/01/1982 - "Effects of lysine-vasopressin and 1-deamino-8-D-arginine-vasopressin on memory in healthy individuals and diabetes insipidus patients."
10/19/1964 - "THE TREATMENT OF DIABETES INSIPIDUS WITH SYNTHETIC LYSINE-VASOPRESSIN BY INHALATION."
07/01/1964 - "Synthetic 8-lysine vasopressin administered as a nasal spray to three patients with diabetes insipidus resulted in excellent control in one. "
07/01/1964 - "SYNTHETIC LYSINE VASOPRESSIN NASAL SPRAY IN THE TREATMENT OF DIABETES INSIPIDUS."
10/18/1965 - "[Effects of lysine-vasopressin on the nucleic acid content of cancer tissues in vitro]."
05/01/1969 - "[In vitro action of lysine-vasopressin on the concentration of ribo- and deoxyribonucleic acids in malignant cerebral tumors. "
04/01/1994 - "In this study we have investigated the responsiveness of the pituitary-adrenocortical axis to intravenous administration of CRH or lysine vasopressin (LVP) in 16 control dogs, 22 dogs with pituitary-dependent hyperadrenocorticism and five dogs with hyperadrenocorticism due to an adrenocortical tumor, using doses of CRH and LVP that caused equivalent ACTH responses in the control dogs. "
06/05/1999 - "DYNAMIC TESTS: The physiological response of ACTH and also AVP to corticotropin releasing hormone (CRH) in the petrous sinus, the unusual responses of certain corticotropic tumors to dDAVP, or certain forms of ACTH-independent hypercortisolism to lysine vasopressin (LVP) suggest excessive or ectopic expression of RV in corticotropic or adrenal cells: tumorgenesis of these cells could also depend, at least partially, on AVP."
01/01/1980 - "Angiography was performed before and after intraarterial administration of prostaglandin F2 alpha, 8-lysine vasopressin, oxytocin, methylergometrine, noradrenalin, and bradykinin in 62 women with various pelvic tumors. "
|5.||Body Weight (Weight, Body)
08/01/1981 - "Synthetic lysine-vasopressin (2 IU/kg body weight) terminated pregnancy in the rabbit when administered im on day 20, but not when administered on days 8 through 11 of gestation. "
01/01/1986 - "At menstruation, during recording of intrauterine pressure (18 recording sessions in 11 women), intravenous infusion of lysine vasopressin (LVP, 1 ng/min/kg/body weight) induced an increase of the uterine activity and dysmenorrhoea-like symptoms. "
04/01/1997 - "The women participated on days 1, 2 or 3 of two menstrual cycles, with intrauterine pressure recordings and intravenous bolus injections of 10 pmol/kg body weight of lysine vasopressin given 1 h before and at 1, 2 and 3 h after oral administration of 300 mg of the study drug or of placebo. "
09/01/1988 - "The effect of lysine vasopressin infusion (1 pmol/kg body-weight per min) and of bolus injection of a synthetic oxytocin analogue, 1-deamino-2-D-Tyr(OEt)-4-Thr-8-Orn-oxytocin (10 nmol/kg body-weight), were studied. "
01/01/1987 - "In order to test possible effects of lysine-vasopressin (LVP) on basal and LH-RH-stimulated LH and FSH release, an intravenous bolus of LVP (0.06 IU/kg body weight) was injected alone or 10 min before LH-RH (100 micrograms i.v.) in 33 normal women in the follicular, periovulatory and luteal phase of their menstrual cycle. "
|1.||Arginine Vasopressin (Argipressin)
|5.||Posterior Pituitary Hormones
|8.||Adrenocorticotropic Hormone (ACTH)
|1.||Renal Dialysis (Hemodialysis)